BridgeMD
New treatment option for Borderline Personality Disorder
Official title Testing Interventions for Borderline Personality Disorder.
ClinicalTrials.gov ID: NCT06458933
What this study is testing
- What it's testing
- Borderline personality disorder (BPD) is a life-threatening, costly public health crisis affecting \~1-3% of North Americans, with 10% dying by suicide and annual healthcare costs of \~$63k (Canadian Dollars)/patient. Further, people with BPD's intimate relationships are highly disrupted, and their partners report elevated mental health problems but little access to treatment.
- Phase 2: a mid-size study of how well it works
- Which group you join is decided by chance.
A plain-language read of the study's public ClinicalTrials.gov listing. The study team confirms the details.
Who can take part
Ages 19 and older
You may be able to join if
- Participant with borderline personality disorder (BPD) meets full diagnostic criteria for BPD (i.e., five or more BPD diagnostic criteria per the...
- Both members are at least 19-years-old
- Both members consent to study participation
- Both members consent to a member of the research team contacting one of their provided emergency contacts if there are imminent safety concerns.
- Both members consent to having assessment interviews and treatment sessions audio- and video-recorded
See the full eligibility criteria
- Participant with borderline personality disorder (BPD) meets full diagnostic criteria for BPD (i.e., five or more BPD diagnostic criteria per the Diagnostic and Statistical Manual of Mental Disorders-5-TR)
- Both members are at least 19-years-old
- Both members consent to study participation
- Both members consent to a member of the research team contacting one of their provided emergency contacts if there are imminent safety concerns.
- Both members consent to having assessment interviews and treatment sessions audio- and video-recorded
- Both members members reside in Ontario (with no plan to leave the province during the course of the study)
- Both members members are fluent in English
- Both members are willing to receive emails about the study
- Both members have regular internet access from a private location for completion of study appointments EXCLUSION:
- Severe intimate partner violence in their relationship in the past year (Endorsement of severe intimate partner violence items on Conflict Tactics Scale-2)
- DSM-5 criteria A and B of schizophrenia, not better accounted for by BPD
- Hospitalization in the past year for mania, or mania in the past three months
- A substance/alcohol use disorder that is likely to require medical intervention (e.g., detoxification) to reduce use
- A medical condition that is likely to require hospitalization within the next year
- Scaled score below 70 on the Test of Premorbid Functioning, suggesting impaired intelligence and/or probable traumatic brain injury
- Either participant in the dyad is not able to show proof of identification upon request at any point throughout the study or is not able to provide an accurate phone number or address upon request.
- The individual with BPD is currently receiving an empirically-supported BPD treatment and is unwilling to pause the therapy for the duration of the active treatment phase
The study team makes the final eligibility decision.
Where it's taking place
- Toronto, California, Canada
Compensation & support
A stipend or compensation may be offered.
Compensation mentioned.
ClinicalTrials.gov doesn't provide a reliable structured field for payment or travel support - confirm details with the study team.
Questions & answers
Do participants get paid in this trial?
This study's listing includes signals that participants may be compensated or receive a stipend. Amounts vary and are set by the study team - confirm the details with them.
Is it free to join, and do I need insurance?
Searching and applying through BridgeMD is free. In clinical trials the study-related treatment and visits are generally provided at no cost to you. You usually don't need insurance to take part - confirm specifics with the study team.
How long does this study last?
The listing doesn't state an exact length. The study team walks you through the schedule and number of visits before you decide to enroll.
Who can join this trial?
This study is enrolling all sexes, 19 years and older. The study team makes the final eligibility decision.
Where is this trial taking place?
Study sites include Toronto, California, Canada. Enter your location above to see the nearest site and check your eligibility.
Explore other conditions
BridgeMD is an information and trial-matching tool - not medical advice, and not the study sponsor. Details come from ClinicalTrials.gov; the study team decides eligibility.